Future Events

11
Oct
2023
Image
""

The EADV Congress

The upcoming EADV Congress taking place from October 11th-14th, 2023 in Berlin, Germany, will showcase cutting edge science and the latest innovation in Dermatology & Venereology. This annual international congress will bring healthcare professionals, organisations, and industry leaders from across the world to discuss the scientific advances and research occurring in the field. The event promises to be interactive and cover hot topics as well as hands-on workshops, sub-specialty sessions, industry sessions, and late-breaking news sessions. 
July 2023 | IE-P-BK-PSO-2300116
Off

Past Events

25
Mar
2022
Image
""

Evolution in Rheumatology for Nurses Highlights 2022

The Evolution in Rheumatology for Nurses Highlights 2022 meeting is part of an ongoing series. The meeting consisted of a series of 4 sessions presented by Dr Maria Mouyis, Dr Iona Thorne, Professor Alison Leary MBE and Ms Alison Kent. The meeting aimed to enhance patient care and outcomes for Rheumatology Nurse Specialists, by providing the latest research and clinical practice in the field.
  • Dr Maria Mouyis
  • Responsive image
    Dr Maria Mouyis

    Consultant Physician and Rheumatologist
    Luton and Dunstable University Hospital

    Disclosures: Galapagos, Pfizer and UCB Pharma Ltd.
  • Dr Iona Thorne
  • Responsive image
    Dr Iona Thorne

    Consultant Obstetric Physician
    Chelsea and Westminster Hospital NHS Foundation Trust

    Disclosures: British Society of Rheumatology, UCB Pharma Ltd.
  • Professor Alison Leary MBE
  • Responsive image
    Professor Alison Leary MBE

    Professor of Healthcare and Workforce Modelling
    London South Bank University

    Disclosures: Coloplast PLC, MSD, Health Foundation, British Society of Echocardiography, Burdett Trust, Health Education England, Queen Nursing Institute, LCN UK, BASICS Elected representative London RCN PNC and UCB Pharma Ltd.
  • Ms Alison Kent
  • Responsive image
    Ms Alison Kent

    Rheumatology Nurse Manager
    Salisbury NHS Foundation Trust

    Disclosures: Lilly, Pfizer, Janssen, Nordic, Bristol Myers Squibb, Merck Sharpe and Dohme, Galapagos, AbbVie, Royal College of Nursing Rheum Forum Committee and UCB Pharma Ltd.
July 2023 | IE-P-BK-PSO-2300116
16
Jun
2022
Image
""

Case Challenge: Treating Women of Childbearing Age with Psoriasis and Joint Involvement

The following webinar, Case Challenge: Treating Women of Childbearing Age with Psoriasis and Joint Involvement was led by Professors Paolo Gisondi and Luca Idolazzi. The professors looked at a clinical case challenge of psoriatic arthritis and psoriasis between women of childbearing age, and the role of Cimzia® (certolizumab pegol) in psoriatic disease. During the webinar the professors focused on evidence-based methods and gave opportunity to reflect on current treatment plans.
  • Professor Paolo Gisondi
  • Responsive image
    Professor Paolo Gisondi

    Associate Professor of Dermatology and Venereology
    University of Verona, Italy

    Disclosures: AbbVie, Almirall, Amgen, Bristol-Myers Squibb, Eli-Lilly, Janssen, Leo Pharma, Novartis, Pierre Fabre, Sanofi, Sandoz, UCB Pharma Ltd
  • Professor Luca Idolazzi
  • Responsive image
    Professor Luca Idolazzi

    Associate Professor of Rheumatology
    University of Verona, Italy

    Disclosures: AbbVie, Amgen, Eli-Lilly, Janssen, Novartis, UCB Pharma Ltd.
July 2023 | IE-P-BK-PSO-2300116
04
Oct
2022
Image
""

Evolution in Rheumatology Highlights 2022

The Evolution in Rheumatology meeting 2022 is part of an ongoing series for Rheumatology Consultants and Senior Registrars. The meeting was chaired by Professor Karl Gaffney and Dr Raj Sengupta. A range of presentations and workshops was offered by a panel of experts sharing the latest research and clinical practises in rheumatology.
  • Professor Karl Gaffney
  • Responsive image
    Professor Karl Gaffney

    Consultant Rheumatologist
    Norfolk and Norwich University Hospitals NHS Foundation Trust

    Disclosures: AbbVie, UCB Pharma Ltd. Advisory board/Consultancy: AbbVie, Celltrion, Lilly, Novartis, UCB Pharma Ltd.
  • Dr Raj Sengupta
  • Responsive image
    Dr Raj Sengupta

    Consultant Rheumatologist
    Bath, UK
    Royal National Hospital for Rheumatic Disease

    Disclosures: AbbVie, Biogen, Celgene, Eli Lilly, MSD, Novartis, Roche and UCB Pharma Ltd
July 2023 | IE-P-BK-PSO-2300116
14
Oct
2022
Image
""

DNA meeting 2022

The Dermatology Nurse Academy meeting 2022 was a highly anticipated event in our ongoing webinar series for nurses. It offered talks on topics such as ‘A Year in Review’, ‘Psoriasis Through the Ages’, and ‘The Future of Specialist Nursing’. Our speakers included Dr Ashley Spencer, Professor Shernaz Walton and Professor Alison Leary. This event is one that most attendees look forward to and gathers much discussion.
  • Dr Ashley Spencer
  • Responsive image
    Dr Ashley Spencer

    Imperial College Healthcare NHS Trust                                    

    Disclosures: UCB Pharma Ltd
  • Professor Alison Leary MBE
  • Responsive image
    Professor Alison Leary MBE

    Professor of Healthcare and Workforce Modelling
    London South Bank University

    Disclosures: Coloplast PLC, MSD, Health Foundation, British Society of Echocardiography, Burdett Trust, Health Education England, Queen Nursing Institute, LCN UK, BASICS Elected representative London RCN PNC and UCB Pharma Ltd.
  • Professor Shernaz Walton
  • Responsive image
    Professor Shernaz Walton

    Consultant Dermatologist and Research Lead
    Hull Teaching Hospitals NHS Trust

    Disclosures: Project Board Meetings for AbbVie, Novartis and Leo Pharma, Amgen, Clinical Trials of Biologics. Speaker meetings for Celgene and UCB Pharma Ltd
July 2023 | IE-P-BK-PSO-2300116
24
Apr
2023
Image
""

DNA webinar

The Dermatology Nurse Academy webinar, titled ‘PASI 90 vs PASI 100 – Looking to the future of skin clearance’, was an insightful and informative event for dermatology specialist Nurses. We are pleased to have held this event as part of the Dermatology Nurse Academy series. The webinar featured illuminating talks from our experts, Ms. Lisa McGovern, Dr. Richard Woolf, and Ms. Lucy Moorhead, who all offered valuable discussions. The webinar was joined by an exceptional 52 nurses who eagerly participated in the event.
  • Lucy Moorhead
  • Responsive image
    Lucy Moorhead

    St John's Institute of Dermatology,
    Guys and St Thomas NHS Foundation Trust

    Disclosures: AbbVie, Almirall, Bristol-Myers Squibb, Janssen-Cilag, Leo Pharma, Lilly, Novartis, Pfizer and UCB Pharma Ltd
  • Dr Richard Woolf
  • Responsive image
    Dr Richard Woolf

    Consultant Dermatologist
    Guy’s and St Thomas’ NHS Foundation Trust

    Disclosures: AbbVie, Eli Lilly, Leo Pharma, Janssen-Cilag, Novartis, Sandoz, Sanofi and UCB Pharma Ltd
  • Ms Lisa McGovern
  • Responsive image
    Ms Lisa McGovern

    Consultant Dermatologist
    Ashford and St Peter’s Hospitals NHS Foundation Trust

    Disclosures: AbbVie, Almirall, BMS, Janssen Cilag, Leo, Lilly, Novartis, ONO Pharma, Pfizer and UCB
July 2023 | IE-P-BK-PSO-2300116
19
May
2023
Image
""

Pharmacist Evolution in Rheumatology 2023

The inaugural Pharmacist Evolution in Rheumatology 2023 meeting was held on the 19th of May, at the Leonardo Royal Hotel London Tower Bridge. This event is designed for Rheumatology Pharmacists and was chaired by Ms Kalveer Flora and Karl Gaffney. The event featured valuable discussions around various topics including Psoriatic arthritis (PsA), Pregnancy, Myositis and Lupus. 
  • Ms Kalveer Flora
  • Responsive image
    Ms Kalveer Flora

    Chief Pharmaceutical Officer's Clinical Fellow and Rheumatology Lead Pharmacist
    Chair, Rheumatology Pharmacists UK (RPUK)
    Lead Pharmacist, Specialised Rheumatology CRG for NHS England
    Pharmacy Department | Northwick Park, Central Middlesex and Ealing Hospital
    London North West University Healthcare NHS Trust                                                                 

    Disclosures: AbbVie, Eli Lilly, Mylan, Roche, Amgen, Novartis, Sanofi, Sandoz and UCB Pharma Ltd
  • Professor Karl Gaffney
  • Responsive image
    Professor Karl Gaffney

    Consultant Rheumatologist
    Norfolk and Norwich University Hospitals NHS Foundation Trust

    Disclosures: AbbVie, UCB Pharma Ltd. Advisory board/Consultancy: AbbVie, Celltrion, Lilly, Novartis, UCB Pharma Ltd.
July 2023 | IE-P-BK-PSO-2300116
19
Sep
2023
Image
""

BDNG 32nd Annual Conference

UCB will be attending the upcoming British Dermatological Nursing Group (BDNG) 32nd Annual Meeting on 19th - 21st September 2023 at Harrogate Convention Centre. This annual meeting brings together Dermatology Specialist Nurses from across the UK. This year, we have a sponsored symposium on Wednesday 20th September from 12:10 - 12:55. We are excited to be joined by Dr Keith Wu, Consultant Dermatologist at York and Scarborough Teaching Hospitals NHS Foundation Trust, and Mr Emmanuel Toni, Advanced Nurse Practitioner at Guy's and St Thomas' NHS Foundation Trust, for our sponsored symposium: Real world experience with BIMZELX (bimekizumab). This event ensures the opportunity to learn and discover the latest advancements in the field of Dermatology Nursing. We look forward to seeing you there!
August 2023 | GB-P-BK-PSO-2300204
Off

Report adverse events

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk and hpra.ie/homepage/about-us/report-an-issue.

Adverse events should also be reported to UCB Pharma Ltd Email: UCBCares.UK@ucb.com and UCBCares.IE@ucb.com.

Feature requests

Help us to grow our resource the way you want it to grow.

Get in touch now

Date of preparation: July 2023
IE-P-BK-PSO-2300115